Business
Press Release Oct 02 2024
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated October 02, 2024, titled "Zydus receives tentative approval from USFDA for Enzalutamide Tablets, 40 mg and 80 mg".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated October 02, 2024, titled \"Zydus receives tentative approval from USFDA for Enzalutamide Tablets, 40 mg and 80 mg\". View Attachment","length":353,"tagName":"div"}]